PD-L1 Expression on Circulating Antigen Presenting Macrophages in Blood Predicts PFS & OS in an Array of Metastatic Cancer Types Treated with PD-L1/PD-1 ImmunotherapiesJOURNAL OF IMMUNOLOGYIF3.42023-05-010OA
Extracellular vesicles budding from stromal macrophages in the blood of metastatic non-small cell lung cancer patients correlates with poor survivalCANCER RESEARCHIF16.62023-04-040PRE
Tumor macrophage fusion cells detected in the circulation of metastatic breast cancer patients is prognostic for rapid progression and deathCANCER RESEARCHIF16.62023-04-040PRE
Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal CancerBIOMEDICINESIF3.92022-11-112OAAI
CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcomeBREAST CANCER RESEARCHIF5.62022-05-2312OAAI
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomesNPJ PRECISION ONCOLOGYIF82021-03-1915OAAI
Circulating stromal cells in resectable pancreatic cancer is associated with high pathological stage and poor clinical outcomesCANCER RESEARCHIF16.62020-08-150PRE
Expression of pd-l1 on circulating stromal cells predicts immunotherapy response in unresectable non-small cell lung carcinoma after definitive chemoradiotherapyCANCER RESEARCHIF16.62020-08-150PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向